☆ 4.6 Article

The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine

ALLERGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Allergy

SARS-CoV-2, COVID-19, skin and immunology - What do we know so far?

Natalijia Novak et al.

Summary: COVID-19 caused by SARS-CoV-2 can lead to respiratory symptoms as well as skin lesions and vascular system abnormalities in some patients. Understanding and identifying these skin manifestations and vascular changes are crucial for diagnosis and treatment of COVID-19 patients.

ALLERGY (2021)

添加到收藏夹

Article Allergy

COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper

Oliver Pfaar et al.

Summary: This study analyzed scientific information on COVID-19 from various sources and developed recommendations for optimal management of allergy clinics during the current COVID-19 pandemic. The international Position Paper provides recommendations on operational plans and procedures to maintain high standards in the daily clinical care of allergic patients while ensuring necessary safety measures.

ALLERGY (2021)

添加到收藏夹

Review Allergy

Polyethylene Glycol-Induced Systemic Allergic Reactions (Anaphylaxis)

Priya Sellaturay et al.

Summary: This study reports 5 cases of confirmed PEG allergy, with most cases related to medications containing PEGs. Skin tests showed positive reactions in 3 cases, with 2 cases experiencing allergic reactions following the intradermal test.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

添加到收藏夹

Article Allergy

ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper

Ludger Klimek et al.

Summary: In response to severe anaphylaxis cases following the COVID-19 vaccine BNT162b2, the EAACI has issued preliminary recommendations emphasizing the importance of understanding severe allergic reactions and not excluding mild to moderate allergic patients from vaccination. Healthcare practitioners must be adequately prepared to recognize and treat anaphylaxis, and a mandatory observation period post-vaccination is recommended.

ALLERGY (2021)

添加到收藏夹

Editorial Material Allergy

Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?

Beatriz Cabanillas et al.

ALLERGY (2021)

添加到收藏夹

Article Allergy

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines

Milena Sokolowska et al.

Summary: The discussion focuses on the management and prevention of vaccine allergic reactions, providing a detailed algorithm for diagnosing and treating severe allergic reactions, along with recommendations for appropriate medications and equipment. A workup for identifying potential allergenic components in vaccines is proposed, along with a suggested international collaborative approach to reduce the risk of allergic reactions to COVID-19 vaccines.

ALLERGY (2021)

添加到收藏夹

Review Medicine, General & Internal

Maintaining Safety with SARS-CoV-2 Vaccines

Mariana C. Castells et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Review Allergy

Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation

Ludger Klimek et al.

Summary: Following the emergency use authorization of the mRNA-1273 vaccine, two mRNA vaccines have been used to prevent COVID-19, but reports of allergic reactions have surfaced in the UK, Canada, and the US. The culprit may be the PEG-2000 contained in both vaccines as a potential trigger.

ALLERGY (2021)

添加到收藏夹

Editorial Material Allergy

Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients

P. Rojas-Perez-Ezquerra et al.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Review Allergy

Vaccines and Allergic reactions: The past, the current COVID-19 pandemic, and future perspectives

Vanitha Sampath et al.

Summary: Vaccines are crucial tools in public health, with the COVID-19 vaccines expected to have a positive impact globally. While serious allergic reactions are rare, it is important to consider their mechanisms, clinical implications, and potential causes, as well as to review implications for individual diagnosis, management, and vaccine manufacturing for future research.

ALLERGY (2021)

添加到收藏夹

Letter Allergy

Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine

Priya Sellaturay et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2021)

添加到收藏夹

Article Allergy

Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy

Alexander Troelnikov et al.

Summary: Patients with a history of PEG allergy showed positive skin test results after receiving the BNT162b2 vaccine, while traditional PEG skin testing yielded negative results for 2 out of 3 patients. One patient exhibited cross-reactivity to PEG and polysorbate, leading to co-sensitization to both the BNT162b2 and AZD1222 vaccines.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Letter Allergy

COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: COVID-19 vaccine anaphylaxis: PEG or not?

Beatriz Cabanillas et al.

ALLERGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia et al.

Summary: To date, there are no immunological data on COVID-19 heterologous vaccination schedules in humans. This study evaluated the immunogenicity and reactogenicity of administering BNT162b2 as a second dose in individuals primed with ChAdOx1-S. The results showed that BNT162b2 induced a robust immune response in individuals prime vaccinated with ChAdOx1-S, with an acceptable and manageable reactogenicity profile.

LANCET (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Heterologous vaccine regimens against COVID-19

Talita Duarte-Salles et al.

LANCET (2021)

添加到收藏夹

Review Allergy

COVID-19 Vaccine-associated Anaphylaxis and Allergic Reactions: Consensus Statements of the KAAACI Urticaria/Angioedema/Anaphylaxis Working Group

Mi Ae Kim et al.

Summary: In the era of the novel coronavirus epidemics, COVID-19 vaccines have been recognized as one of the most effective public health interventions to control the pandemic. However, severe allergic reactions can occur after vaccinations, with potential allergenic/immunogenic excipients such as PEG and polysorbate 80 in COVID-19 vaccines. Contraindications to vaccination include a history of severe allergic reactions to the vaccine or proven hypersensitivity to a vaccine component.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2021)

添加到收藏夹

Review Allergy

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Ahmet Kursat Azkur et al.

ALLERGY (2020)

添加到收藏夹

Review Allergy

A compendium answering 150 questions on COVID-19 and SARS-CoV-2

Carmen Riggioni et al.

ALLERGY (2020)

添加到收藏夹

Article Allergy

Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI)

Milena Sokolowska et al.

ALLERGY (2020)

添加到收藏夹

Review Allergy

Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs

Ana Dioun Broyles et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Immune-mediated adverse reactions to vaccines

Cosby A. Stone et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)

添加到收藏夹

Article Allergy

Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized

Cosby A. Stone et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

添加到收藏夹

Review Allergy

Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology

A. Muraro et al.

ALLERGY (2017)

添加到收藏夹

Article Allergy

In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper

C. Mayorga et al.

ALLERGY (2016)

添加到收藏夹

Review Allergy

Immediate-type hypersensitivity to polyethylene glycols: a review

E. Wenande et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2016)

添加到收藏夹

Review Allergy

The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease

H. J. Hoffmann et al.

ALLERGY (2015)

添加到收藏夹

Article Allergy

International Consensus on drug allergy

P. Demoly et al.

ALLERGY (2014)

添加到收藏夹

Article Allergy

In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones

A. Aranda et al.

ALLERGY (2011)

添加到收藏夹

Article Allergy

Clinical features and severity grading of anaphylaxis

SGA Brown

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)

添加到收藏夹

Article Allergy

The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams

MJ Torres et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2004)

添加到收藏夹

Article Allergy

Diagnosis of immediate allergic reactions to beta-lactam antibiotics

MJ Torres et al.

ALLERGY (2003)

添加到收藏夹

Article Allergy

Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations

W Aberer et al.

ALLERGY (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.